{"title":"来自临床甲状腺学编辑的问候","authors":"","doi":"10.1089/ct.2023;35.345-346","DOIUrl":null,"url":null,"abstract":"Clinical Thyroidology®Vol. 35, No. 9 Greetings from the EditorFree AccessGreetings From the Editor of Clinical ThyroidologyPublished Online:13 Sep 2023https://doi.org/10.1089/ct.2023;35.345-346AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail Greetings to our readers. This month's issue of Clinical Thyroidology includes several special highlights that are not to be missed. First, we begin with the next fireside chat in the American Thyroid Association's continuing series celebrating our centennial anniversary. In this discussion, Drs. Victor Bernet and Anne Cappola reflect on their thoughts and perspectives on the topic of thyroid hormone use and abuse, framed in the history of the development of thyroid hormone replacement. Then, as part of our ongoing collaboration with the International Thyroid Oncology Group (ITOG), in an editorial Drs. Laura Boucai, Ashish Chintakuntlawar, and David Shonka, Jr., give a brief summary of the ITOG community and its past and current work in coordinating the group's available clinical trials of various advanced thyroid cancers. I hope that this excellent summary is helpful to clinicians worldwide who are managing the care of patients with metastatic or advanced disease.Moving on to the topic of pediatric thyroid disease, Dr. Gary Francis reviews a study on serum thyroid function tests in children with Down syndrome. Drs. Maryam Makowski and Elizabeth McAninch then provide their perspective on a study examining low T3 syndrome in malnourished hospitalized patients, while Dr. Anupam Kotwal reviews a study reporting a real-world experience with teprotumumab and tocilizumab use in patients with moderate-to-severe steroid-resistant thyroid eye disease.On the topic of thyroid nodules and thyroid cancer, Drs. Kristen HoSang and Lindsay Kuo review a study assessing the role of age in patients who undergo active surveillance of small, sonographically low-risk thyroid nodules. Meanwhile, Drs. Jessica Bindra, Matti Gild, and Venessa Tsang examine a study reporting the benefit of preoperative molecular testing of cytologically high-risk thyroid nodules, while Drs. Paul Stewardson and Mayumi Endo review how the allelic frequency of BRAF V600E and TERT promoter mutations in thyroid nodules may be a useful predictor of malignancy. The potential benefit of microwave ablation for the treatment of select micropapillary thyroid cancers is reviewed by Dr. Jie Liu. Dr. Sara Ahmadi discusses a recent study on the comparison of diffuse sclerosing, classic, and tall-cell variant papillary thyroid cancers. Finally, Drs. Ricardo Villela and Ricardo Correa summarize a recent study examining the adverse effects of radioactive iodine ablation on the lacrimal and salivary glands.I invite everyone to visit our various social media channels, where we recap the featured highlights from each month's issue and discuss other topics related to the latest clinical thyroid literature. All are welcome to join us at:Twitter:https://twitter.com/clinicalthyroid(@clinicalthyroid)Facebook:https://www.facebook.com/ThyroidAssociationLinkedIn:https://www.linkedin.com/company/american-thyroid-associationYoutube:https://www.youtube.com/user/thyroidorgMy thanks again to the editorial board of Clinical Thyroidology for the Public [CTFP] (https://www.thyroid.org/patient-thyroid-information/ct-for-patients), as led by Dr. Alan Farwell, for their work in providing short summaries of our Clinical Thyroidology articles each month. These freely available, quicker reads are helpful to patients and to the general public who are interested in learning more about recently published studies in the clinical thyroid literature.We will continue to provide reviews, commentaries, editorials, and perspectives on the most relevant clinical thyroid studies from the published literature. Guidelines for submitting Letters to the Editor and select Guest Editorials that cover timely and innovative aspects of clinical thyroid disease management may be found at https://home.liebertpub.com/publications/clinical-thyroidologyand174/623/for-authors.Thank you again for your interest in Clinical Thyroidology. Please feel free to send me any questions or comments at [email protected].Warmest regards,Angela M. Leung, MD, MScEditor-in-Chief, Clinical ThyroidologyFiguresReferencesRelatedDetails Volume 35Issue 9Sep 2023 Information© Copyright 2023, Mary Ann Liebert, Inc.To cite this article:Greetings From the Editor of Clinical Thyroidology.Clinical Thyroidology®.Sep 2023.345-346.http://doi.org/10.1089/ct.2023;35.345-346Published in Volume: 35 Issue 9: September 13, 2023PDF download","PeriodicalId":72629,"journal":{"name":"Clinical thyroidology","volume":"26 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Greetings From the Editor of <i>Clinical Thyroidology</i>\",\"authors\":\"\",\"doi\":\"10.1089/ct.2023;35.345-346\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Clinical Thyroidology®Vol. 35, No. 9 Greetings from the EditorFree AccessGreetings From the Editor of Clinical ThyroidologyPublished Online:13 Sep 2023https://doi.org/10.1089/ct.2023;35.345-346AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail Greetings to our readers. This month's issue of Clinical Thyroidology includes several special highlights that are not to be missed. First, we begin with the next fireside chat in the American Thyroid Association's continuing series celebrating our centennial anniversary. In this discussion, Drs. Victor Bernet and Anne Cappola reflect on their thoughts and perspectives on the topic of thyroid hormone use and abuse, framed in the history of the development of thyroid hormone replacement. Then, as part of our ongoing collaboration with the International Thyroid Oncology Group (ITOG), in an editorial Drs. Laura Boucai, Ashish Chintakuntlawar, and David Shonka, Jr., give a brief summary of the ITOG community and its past and current work in coordinating the group's available clinical trials of various advanced thyroid cancers. I hope that this excellent summary is helpful to clinicians worldwide who are managing the care of patients with metastatic or advanced disease.Moving on to the topic of pediatric thyroid disease, Dr. Gary Francis reviews a study on serum thyroid function tests in children with Down syndrome. Drs. Maryam Makowski and Elizabeth McAninch then provide their perspective on a study examining low T3 syndrome in malnourished hospitalized patients, while Dr. Anupam Kotwal reviews a study reporting a real-world experience with teprotumumab and tocilizumab use in patients with moderate-to-severe steroid-resistant thyroid eye disease.On the topic of thyroid nodules and thyroid cancer, Drs. Kristen HoSang and Lindsay Kuo review a study assessing the role of age in patients who undergo active surveillance of small, sonographically low-risk thyroid nodules. Meanwhile, Drs. Jessica Bindra, Matti Gild, and Venessa Tsang examine a study reporting the benefit of preoperative molecular testing of cytologically high-risk thyroid nodules, while Drs. Paul Stewardson and Mayumi Endo review how the allelic frequency of BRAF V600E and TERT promoter mutations in thyroid nodules may be a useful predictor of malignancy. The potential benefit of microwave ablation for the treatment of select micropapillary thyroid cancers is reviewed by Dr. Jie Liu. Dr. Sara Ahmadi discusses a recent study on the comparison of diffuse sclerosing, classic, and tall-cell variant papillary thyroid cancers. Finally, Drs. Ricardo Villela and Ricardo Correa summarize a recent study examining the adverse effects of radioactive iodine ablation on the lacrimal and salivary glands.I invite everyone to visit our various social media channels, where we recap the featured highlights from each month's issue and discuss other topics related to the latest clinical thyroid literature. All are welcome to join us at:Twitter:https://twitter.com/clinicalthyroid(@clinicalthyroid)Facebook:https://www.facebook.com/ThyroidAssociationLinkedIn:https://www.linkedin.com/company/american-thyroid-associationYoutube:https://www.youtube.com/user/thyroidorgMy thanks again to the editorial board of Clinical Thyroidology for the Public [CTFP] (https://www.thyroid.org/patient-thyroid-information/ct-for-patients), as led by Dr. Alan Farwell, for their work in providing short summaries of our Clinical Thyroidology articles each month. These freely available, quicker reads are helpful to patients and to the general public who are interested in learning more about recently published studies in the clinical thyroid literature.We will continue to provide reviews, commentaries, editorials, and perspectives on the most relevant clinical thyroid studies from the published literature. Guidelines for submitting Letters to the Editor and select Guest Editorials that cover timely and innovative aspects of clinical thyroid disease management may be found at https://home.liebertpub.com/publications/clinical-thyroidologyand174/623/for-authors.Thank you again for your interest in Clinical Thyroidology. Please feel free to send me any questions or comments at [email protected].Warmest regards,Angela M. Leung, MD, MScEditor-in-Chief, Clinical ThyroidologyFiguresReferencesRelatedDetails Volume 35Issue 9Sep 2023 Information© Copyright 2023, Mary Ann Liebert, Inc.To cite this article:Greetings From the Editor of Clinical Thyroidology.Clinical Thyroidology®.Sep 2023.345-346.http://doi.org/10.1089/ct.2023;35.345-346Published in Volume: 35 Issue 9: September 13, 2023PDF download\",\"PeriodicalId\":72629,\"journal\":{\"name\":\"Clinical thyroidology\",\"volume\":\"26 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical thyroidology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1089/ct.2023;35.345-346\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical thyroidology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/ct.2023;35.345-346","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Greetings From the Editor of Clinical Thyroidology
Clinical Thyroidology®Vol. 35, No. 9 Greetings from the EditorFree AccessGreetings From the Editor of Clinical ThyroidologyPublished Online:13 Sep 2023https://doi.org/10.1089/ct.2023;35.345-346AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail Greetings to our readers. This month's issue of Clinical Thyroidology includes several special highlights that are not to be missed. First, we begin with the next fireside chat in the American Thyroid Association's continuing series celebrating our centennial anniversary. In this discussion, Drs. Victor Bernet and Anne Cappola reflect on their thoughts and perspectives on the topic of thyroid hormone use and abuse, framed in the history of the development of thyroid hormone replacement. Then, as part of our ongoing collaboration with the International Thyroid Oncology Group (ITOG), in an editorial Drs. Laura Boucai, Ashish Chintakuntlawar, and David Shonka, Jr., give a brief summary of the ITOG community and its past and current work in coordinating the group's available clinical trials of various advanced thyroid cancers. I hope that this excellent summary is helpful to clinicians worldwide who are managing the care of patients with metastatic or advanced disease.Moving on to the topic of pediatric thyroid disease, Dr. Gary Francis reviews a study on serum thyroid function tests in children with Down syndrome. Drs. Maryam Makowski and Elizabeth McAninch then provide their perspective on a study examining low T3 syndrome in malnourished hospitalized patients, while Dr. Anupam Kotwal reviews a study reporting a real-world experience with teprotumumab and tocilizumab use in patients with moderate-to-severe steroid-resistant thyroid eye disease.On the topic of thyroid nodules and thyroid cancer, Drs. Kristen HoSang and Lindsay Kuo review a study assessing the role of age in patients who undergo active surveillance of small, sonographically low-risk thyroid nodules. Meanwhile, Drs. Jessica Bindra, Matti Gild, and Venessa Tsang examine a study reporting the benefit of preoperative molecular testing of cytologically high-risk thyroid nodules, while Drs. Paul Stewardson and Mayumi Endo review how the allelic frequency of BRAF V600E and TERT promoter mutations in thyroid nodules may be a useful predictor of malignancy. The potential benefit of microwave ablation for the treatment of select micropapillary thyroid cancers is reviewed by Dr. Jie Liu. Dr. Sara Ahmadi discusses a recent study on the comparison of diffuse sclerosing, classic, and tall-cell variant papillary thyroid cancers. Finally, Drs. Ricardo Villela and Ricardo Correa summarize a recent study examining the adverse effects of radioactive iodine ablation on the lacrimal and salivary glands.I invite everyone to visit our various social media channels, where we recap the featured highlights from each month's issue and discuss other topics related to the latest clinical thyroid literature. All are welcome to join us at:Twitter:https://twitter.com/clinicalthyroid(@clinicalthyroid)Facebook:https://www.facebook.com/ThyroidAssociationLinkedIn:https://www.linkedin.com/company/american-thyroid-associationYoutube:https://www.youtube.com/user/thyroidorgMy thanks again to the editorial board of Clinical Thyroidology for the Public [CTFP] (https://www.thyroid.org/patient-thyroid-information/ct-for-patients), as led by Dr. Alan Farwell, for their work in providing short summaries of our Clinical Thyroidology articles each month. These freely available, quicker reads are helpful to patients and to the general public who are interested in learning more about recently published studies in the clinical thyroid literature.We will continue to provide reviews, commentaries, editorials, and perspectives on the most relevant clinical thyroid studies from the published literature. Guidelines for submitting Letters to the Editor and select Guest Editorials that cover timely and innovative aspects of clinical thyroid disease management may be found at https://home.liebertpub.com/publications/clinical-thyroidologyand174/623/for-authors.Thank you again for your interest in Clinical Thyroidology. Please feel free to send me any questions or comments at [email protected].Warmest regards,Angela M. Leung, MD, MScEditor-in-Chief, Clinical ThyroidologyFiguresReferencesRelatedDetails Volume 35Issue 9Sep 2023 Information© Copyright 2023, Mary Ann Liebert, Inc.To cite this article:Greetings From the Editor of Clinical Thyroidology.Clinical Thyroidology®.Sep 2023.345-346.http://doi.org/10.1089/ct.2023;35.345-346Published in Volume: 35 Issue 9: September 13, 2023PDF download